Literature DB >> 7242779

Incorporation of fucose and leucine into PNS myelin proteins in nerves undergoing early Wallerian degeneration.

R G Peterson, S Baughman, D M Scheidler.   

Abstract

The simultaneous incorporation of [3H]fucose and [1-14C]leucine into normal rat sciatic nerve was examined using an in vitro incubation model. A linear rate of protein precursor uptake was found in purified myelin protein over 1/2-6 hr of incubation utilizing a supplemented medium containing amino acids. This model was then used to examine myelin protein synthesis in nerves undergoing degeneration at 1-4 days following a crush injury. Data showed a statistically significant decrease in the ratio of fucose to leucine at 2, 3, and 4 days of degeneration, which was the consequence of a significant increase in leucine uptake. These results, plus substantial protein recovery in axotomized nerves, are indicative of active synthesis of proteins that purify with myelin during early Wallerian degeneration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7242779     DOI: 10.1007/bf00964838

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Ultrastructure and biochemistry of myelin after isoniazid-induced nerve degeneration in rats.

Authors:  C P Sea; R G Peterson
Journal:  Exp Neurol       Date:  1975-08       Impact factor: 5.330

2.  THE NEURILEMMA CELL IN PERIPHERAL NERVE DEGENERATION AND REGENERATION.

Authors:  D SATINSKY; F A PEPE; C N LIU
Journal:  Exp Neurol       Date:  1964-06       Impact factor: 5.330

3.  The effect of diabetes, insulin and Wallerian degeneration on leucine metabolism of isolated rat sciatic nerves.

Authors:  M G Buse; H F Herlong; D A Weigand; S S Spicer
Journal:  J Neurochem       Date:  1976-12       Impact factor: 5.372

4.  Leucine oxidation in brain slices and nerve endings.

Authors:  E R Chaplin; A L Goldberg; I Diamond
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

5.  The ultrastructure of degenerating rat sciatic nerves.

Authors:  A M Calabretta; B L Munger; W P Graham
Journal:  J Surg Res       Date:  1973-05       Impact factor: 2.192

6.  Histochemistry of myelin. XV. Changes in the myelin proteins of the peripheral nerve undergoing Wallerian degeneration--electrophoretic and microdensitometric observations.

Authors:  C W Adams; J Csejtey; J F Hallpike; O B Bayliss
Journal:  J Neurochem       Date:  1972-09       Impact factor: 5.372

7.  Myelin synthesis in vitro: a comparative study of central and peripheral nervous tissue.

Authors:  F A Rawlins; M E Smith
Journal:  J Neurochem       Date:  1971-10       Impact factor: 5.372

8.  Synthesis of nucleic acids in the Schwann cells as the early cellular response to nerve injury.

Authors:  B Oderfold-Nowak; S Niemierko
Journal:  J Neurochem       Date:  1969-02       Impact factor: 5.372

9.  Branched chain amino acid metabolism in the retina of diabetic rats.

Authors:  R Frayser; M G Buse
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

10.  Morphological localization of PNS myelin proteins.

Authors:  R G Peterson; R W Gruener
Journal:  Brain Res       Date:  1978-08-18       Impact factor: 3.252

View more
  3 in total

1.  Myelination of regenerating sciatic nerve of the rat: lipid components and synthesis of myelin lipids.

Authors:  M Alberghina; M Viola; F Moschella; A M Giuffrida
Journal:  Neurochem Res       Date:  1983-02       Impact factor: 3.996

2.  Synthesis of myelin, particulate, and soluble protein subfractions of rat sciatic nerve during the early stage of Wallerian degeneration: a comparison of metabolic studies using double and single isotope methods and recovery.

Authors:  M E Bell; R G Peterson; R C Wiggins
Journal:  Neurochem Res       Date:  1982-01       Impact factor: 3.996

3.  Altered metabolic incorporation of fucose and leucine into PNS myelin of 25-week-old diabetic (C57BL/Ks [db/db]) mice: effects of untreated diabetes on nerve metabolism.

Authors:  M G Chez; R G Peterson
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.